1. Japan Stocks

  2. •

    Health technology

  3. •

    Medical specialties
Rion Co., Ltd.

Rion Co., Ltd.

18.20
EUR
-0.10
(-0.55%)
181.28MMarket Cap
Oct 29Next Earn
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
2026 Y
TTM
Revenue per Share
1,581.52
1,544.16
1,538.01
1,563.42
1,657.6
1,734.1
1,748.41
1,666.22
1,841.95
1,940.75
2,089.84
2,263.46
2,312.18
- -
Basic EPS, GAAP
112.45
117.47
130
114.73
153.77
163.14
144.96
133.27
181.42
146.33
215.46
232.19
271.41
- -
Free Cash Flow per Basic Share
71.57
30.28
129.42
115.25
89.75
64.45
168.21
76.78
142.83
-22.7
13.53
151.27
277.18
- -
Dividend per Share
31.15
25.97
30.8
30.01
30.04
38.06
41.96
45.01
43.04
45.99
44.97
59.98
76.91
- -
Book Value per Share
1,206.27
1,286.01
1,387.86
1,463.04
1,594.19
1,713.99
1,810.87
1,931.15
2,057.39
2,163.3
2,372.88
2,825.09
2,549.47
- -
Tangible Book Value per Share
1,164.52
1,239.15
1,337.06
1,402.7
1,538
1,662.98
1,764.89
1,874.42
1,971.99
1,976.03
2,172.78
2,670.46
2,367.92
- -
Basic Weighted Avg Shares
12
12
12
12
12
12
12
12
12
12
12
12
12
12
Sales/Revenue/Turnover
18,510
18,758
18,859
19,194
20,350
21,290
21,465
20,466
22,636
23,868
25,727
27,878
28,502
- -
Operating Margin (%)
25.85
27.08
26.2
9.73
12.64
12.7
11.58
10.85
13.72
11.92
13.51
14.47
15.3
- -
Depreciation Expense
560
611
634
619
637
730
768
734
715
744
902
1,242
1,404
- -
Net Income, GAAP
1,316
1,427
1,594
1,409
1,888
2,003
1,780
1,637
2,229
1,800
2,652
2,860
3,346
- -
Effective Tax Rate (%)
41.34
41.71
32.62
28.19
28.89
26.69
29.87
32.47
29.7
24.54
24.6
26.68
23.5
- -
Profit Margin (%)
7.11
7.61
8.45
7.34
9.28
9.41
8.29
8
9.85
7.54
10.31
10.26
11.74
- -
Working Capital
8,477
9,016
9,732
10,188
11,021
12,490
13,737
14,302
15,753
14,714
15,431
20,504
17,229
- -
LT Debt
1,316
1,112
495
56
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Total Equity
14,619
15,686
17,039
17,962
19,572
21,043
22,232
23,726
25,289
26,612
29,211
34,803
31,436
- -
Return on Invested Capital (%)
7.54
7.57
8.33
7.22
9.4
9.52
7.9
6.41
8.69
8.1
9.24
9.06
9.85
- -
Return on Capital (%)
8.11
8.29
8.93
7.72
9.93
9.86
8.23
7.13
9.1
6.94
9.51
8.94
10.11
- -
Return on Common Equity (%)
9.81
9.42
9.74
8.05
10.06
9.86
8.22
7.12
9.1
6.93
9.5
8.93
10.1
- -

Capital Structure

JPY

•

in mil. unless spec.
Sep'26
Mar'26
Jun'27
ST Debt
- -
- -
- -
LT Borrowings
- -
- -
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
12
12
12
Market Capitalization
- -
33,252
46,717

Working Capital

JPY

•

in mil. unless spec.
Sep'26
Mar'26
Jun'27
Total Current Assets
23,514
22,683
- -
Cash, Cash Equivalents & STI
7,379
6,014
- -
Accounts Receivable, Net
5,105
5,620
- -
Inventories
8,243
8,035
- -
Total Current Liabilities
4,850
5,455
- -
Payables & Accruals
- -
- -
- -
ST Debt
- -
- -
- -
Deferred Revenue
- -
- -
- -

Growth Rates

JPY

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
6.53%
6.21%
-9.68%
Free Cash Flow
95.76%
182.43%
83.39%
Net Income, GAAP
9.84%
17.82%
16.99%
Sales/Revenue/Turnover
4.3%
6.89%
2.24%
Total Cash Common Dividend
10.42%
12.45%
28.33%

Quarterly Revenue

JPY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
- -
- -
- -
- -
27,878
2026
- -
- -
- -
- -
28,502
2027
- -
- -
- -
- -
- -

Quarterly Earnings Per Share

JPY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
- -
- -
- -
- -
232.19
2026
- -
- -
- -
- -
271.41
2027
- -
- -
- -
- -
- -

Quarterly Dividends Per Share

JPY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
- -
- -
- -
- -
59.98
2026
- -
- -
- -
- -
76.91
2027
- -
- -
- -
- -
- -

Company Description

Company Profile APIChatGPT
CEO
Kiminori Kato
Full Time Employees
1,003
Sector
Health technology
Industry
Medical specialties
Address
3-20-41 Higashimotomachi Tokyo TY Japan 185-8533
IPO Date
May 15, 2000
Website
rion.co.jp
Similar Companies
Intuitive Surgical, Inc. (NASDAQ:ISRG)
Boston Scientific Corporation (NYSE:BSX)
Thermo Fisher Scientific Inc (NYSE:TMO)
Illumina, Inc. (NASDAQ:ILMN)
Abbott Laboratories (NYSE:ABT)
GRAIL, Inc. (NASDAQ:GRAL)
Business
Rion Co., Ltd. develops, manufactures, sells, and services medical devices including hearing instruments and related medical equipment; environmental devices such as sound and vibration measuring instruments and particle counters; and parts and equipment related to these products primarily in Japan. The company's audiological equipment encompasses analog and digital behind-the-ear hearing instruments, trimmer digital behind-the-ear models, in-the-ear ready and custom-made hearing aids, analog body aids, and waterproof hearing instruments; medical equipment includes audiometers and otoacoustic emission screeners under the Rionet brand with over 60 years of history. Sound and vibration measuring instruments comprise sound level meters, vibration meters, seismometers, frequency analyzers, microphones, accelerometers, and recorders; particle counters include airborne, liquid-borne, and viable models used in clean room management for electronics, semiconductors, pharmaceuticals, food manufacturing, and environmental administration. Founded June 21, 1944, and headquartered at 3-20-41 Higashimotomachi, Kokubunji, Tokyo 185-8533, Japan, Rion lists on the Tokyo Stock Exchange Prime Market under ticker 6823 with President and CEO Koki Kato and 1,026 consolidated employees as of March 31, 2024. Recent developments include the renewal of the SupportRoom web service for sound and vibration measuring instruments in July 2024; release of RION Technical Journal volumes 10 through 13 from May 2024 to June 2025; issuance of new shares as restricted stock compensation in July 2025; and consolidated financial results announcements for periods ending June 30, 2025, and March 31, 2025, reflecting ongoing operational enhancements.